[PAR] [TLE] Insulin detemir [SEP] Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin.  Novo Nordisk markets it under the trade name Levemir.  It is an insulin analogue in which a fatty acid (myristic acid) is bound to the lysine amino acid at position B29.  It is quickly absorbed after which it binds to albumin in the blood through its fatty acid at position B29.  It then slowly dissociates from this complex. [PAR] [TLE] Novo Nordisk [SEP] Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in eight countries, and affiliates or offices in 75 countries.  Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a supermajority (75%) of its voting shares.
[PAR] [TLE] Insulin detemir [ SEP ] Insulin detemir is a long - acting human insulin analogue for maintaining the basal level of insulin . Novo Nordisk markets it under the trade name Levemir . It is an insulin analogue in which a fatty acid ( myristic acid ) is bound to the lysine amino acid at position B29 . It is quickly absorbed after which it binds to albumin in the blood through its fatty acid at position B29 . It then slowly dissociates from this complex . [PAR] [TLE] Novo Nordisk [ SEP ] Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd , Denmark , with production facilities in eight countries , and affiliates or offices in 75 countries . Novo Nordisk is controlled by majority shareholder Novo Holdings A / S which holds approximately 25 % of its shares and a supermajority ( 75 % ) of its voting shares .
Insulin detemir is a long-acting human insulin analogue for maintaining the basal level of insulin, Novo Nordisk markets it under which trade name?
Insulin detemir is a long - acting human insulin analogue for maintaining the basal level of insulin , Novo Nordisk markets it under which trade name ?
Levemir
Levemir